
Neovasc NVCN
Annual report 2021
added 12-23-2023
Neovasc Interest Expense 2011-2025 | NVCN
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 133 K | - | - | - | 2.54 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 133 K | 2.54 K | 67.8 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Alphatec Holdings
ATEC
|
24.9 M | $ 21.06 | 0.96 % | $ 3.01 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.35 | 0.54 % | $ 671 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.53 | 2.47 % | $ 122 M | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 95.87 | -0.15 % | $ 141 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 303.14 | -0.45 % | $ 8.55 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Electromed
ELMD
|
78 K | $ 28.72 | -0.38 % | $ 243 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 47.38 | -0.28 % | $ 7.06 K | ||
|
Abbott Laboratories
ABT
|
376 M | $ 125.74 | -0.03 % | $ 219 B | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.29 | 2.49 % | $ 123 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 97.53 | -0.25 % | $ 1.24 B | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 61.91 | -0.59 % | $ 3.36 B | ||
|
LENSAR
LNSR
|
660 K | $ 11.74 | 0.98 % | $ 135 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 157.62 | -0.33 % | $ 11.8 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.83 | 3.35 % | $ 85.3 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 13.53 | -0.29 % | $ 366 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.58 | -0.13 % | $ 122 M | ||
|
AxoGen
AXGN
|
-199 K | $ 32.92 | 0.6 % | $ 1.46 B | ||
|
Orthofix Medical
OFIX
|
-9.62 M | $ 15.21 | -0.82 % | $ 580 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.81 | -0.8 % | $ 1.26 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.82 | -0.78 % | $ 411 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 87.94 | 0.03 % | $ 11.9 B | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 7.73 | 5.46 % | $ 180 M |